跳转至内容
Merck
CN

P0048

Sigma-Aldrich

匹莫林

≥98% (HPLC)

别名:

2-氨基-5-苯基 4(5H)-噁唑酮, 苯异妥因

登录查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C9H8N2O2
化学文摘社编号:
2152-34-3
分子量:
176.17
EC 号:
218-438-8
MDL编号:
MFCD00083197
UNSPSC代码:
12352200
PubChem化学物质编号:
329819998
NACRES:
NA.77

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

方案

≥98% (HPLC)

表单

solid

药品控制

USDEA Schedule IV; Home Office Schedule 4.2; psychotrope (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet

溶解性

DMSO: 28 mg/mL

创始人

Boehringer Ingelheim

储存温度

2-8°C

SMILES字符串

NC1=NC(=O)C(O1)c2ccccc2

InChI

1S/C9H8N2O2/c10-9-11-8(12)7(13-9)6-4-2-1-3-5-6/h1-5,7H,(H2,10,11,12)

InChI key

NRNCYVBFPDDJNE-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

生化/生理作用

匹莫林为中枢神经兴奋剂。
匹莫林为中枢神经兴奋剂。匹莫林用于治疗注意缺陷多动障碍 (ADHD)。匹莫林为第 IV 类精神药品，因其不会造成食欲下降或导致口干而比其他兴奋剂具有优势。

特点和优势

This compound is featured on the Dopamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Boehringer Ingelheim. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

象形图

Exclamation mark
GHS07

警示用语：

Warning

危险声明

H302 + H312 + H332

危险分类

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges, type P3 (EN 143) respirator cartridges

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
029K4630

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Pharmacologic treatments for fatigue associated with palliative care.
Marilyn Kirshbaum
Clinical journal of oncology nursing, 15(4), 438-439 (2011-08-04)
Gideon Koren et al.
Handbook of experimental pharmacology, 205, 169-180 (2011-09-02)
It typically takes many years before an association of a drug with a rare, serious adverse reaction is established. As related to pediatric drug use, evidence is even more erratic, as most drugs are used off labels. To enhance child
Carol S Ramsey et al.
Aviation, space, and environmental medicine, 79(8), 769-773 (2008-08-23)
The impact of pharmacological agents on aviators concerns all flight surgeons. This study tested the related hypotheses that acute fatigue reduces +Gz tolerance and endurance, and that stimulants can partially reverse this impact. Additionally, the researchers attempted to develop a
Coming into focus. Pharmacologic treatment for ADHD.
Mary Ann McDonnell et al.
Advance for NPs & PAs, 1(4), 16-22 (2011-02-16)
Darragh P Devine
Methods in molecular biology (Clifton, N.J.), 829, 155-163 (2012-01-11)
Traditional models of neuropsychiatric disorders consist of attempts to replicate the broad spectrum of behavioural and neurochemical sequelae that characterize a specific disorder. However, these disorders comprise complex constellations of symptoms, including emotional instability, perseverative thoughts, and aberrant behaviours. Close
查看所有相关文献

商品

Dopamine Receptors

We offer many products related to dopamine receptors for your research needs.

多巴胺受体

我们可提供多种多巴胺受体相关的产品，满足您的各类研究需求。

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持